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Abstract
Background: A recent paper reported the outcomes of a study examining a new self-guided internet-delivered treatment,
the Wellbeing Course, for symptoms of anxiety or depression. This study found the intervention resulted in significant
symptom reductions. It also found that automated emails increased treatment completion and clinical improvements in a
subsample with elevated anxiety and depression.
Aims: To examine the clinical outcomes and the effect of automated emails at 12 months post-treatment.
Method: Participants, who were randomly allocated to a Treatment Plus Automated Emails Group (TEG; n = 100), a standard
Treatment Group (TG; n = 106) or delayed-treatment Waitlist Control Group (Control; n = 51), were followed up at 12 months
post-treatment. Eighty-one percent, 78% and 87% of participants in the TEG, TG and treated Waitlist Control Group
provided symptom data at 12-month follow-up, respectively. The primary outcome measures were the Patient Health
Questionnaire-9 Item Scale (PHQ-9) and the Generalized Anxiety Disorder-7 Item Scale (GAD-7).
Results: Significant improvements in symptoms of anxiety and depression were observed over time in both the TEG and TG
(Fs .69, ps ,.001) these were sustained from post-treatment to 12-month follow-up (ps ..05), and were associated with
large effect sizes. No statistically significant differences in symptoms were found between the TEG and TG at post-treatment,
3-month or 12-month follow-up. Previously reported symptom differences between TEG and TG participants with comorbid
symptoms were no longer present at 12-month follow-up (ps ..70).
Conclusions: The overall benefits of the Wellbeing Course were sustained at 12-month follow-up. Although automated
emails facilitated Course completion and reductions in symptoms for participants with comorbid anxiety and depression
from pre-post treatment, these differences were no longer observed at 12-month follow-up. The results indicate that
automated emails promote more rapid treatment response for people with elevated and comorbid symptoms, but may not
improve longer term outcomes.
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Introduction
Self-guided internet-delivered psychological interventions for
anxiety and depressive disorders have considerable public health
potential. However, more than 90% of consumers typically
withdraw after two sessions [1,2] and, consequently may not
receive a dose of therapeutic content sufficient to lead to sustained
improvement. Self-guided internet interventions that include
strategies to facilitate adherence have considerable potential for
optimizing outcomes. Trials of self-guided internet interventions
for depression [3,4] and social phobia [5,6,7] show that automated
reminder emails increased completion rates and effect sizes relative
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to earlier trials without automated reminders. Automated emails
may be particularly suitable as a medium for providing reminders
given their ubiquity and low cost.
A recent paper reported an evaluation of a new self-guided
internet-delivered treatment, the Wellbeing Course, for symptoms of
anxiety or depression [8]. Participants had no contact with
clinicians prior to or during treatment and were randomly
allocated to receive the Wellbeing Course administered with
automated emails (Treatment Plus Automated Email Group:
TEG, n = 100), without automated emails (Treatment Group: TG,
n = 106) or to a Waitlist Control Group (Control Group; n = 51),
who subsequently received treatment. At post-treatment, partic-
ipants in the two Treatment Groups obtained similar and
significant improvements on measures of anxiety and depression
relative to the Control Group. However, those participants
receiving automated emails obtained higher rates of course
completion, defined as having read all five lessons of the course,
than those not receiving emails (58% v. 35%). While no overall
differences in symptom improvement were found between the
Treatment Groups, a subgroup of participants with comorbid
anxiety and depression, that is, participants with elevated
symptoms of both anxiety and depression, obtained superior
reductions in symptoms when they received automated emails
compared to when they did not receive the emails. The pattern of
these results was sustained at 3-month follow-up.
An outstanding question is whether these results are sustained in
the longer term. Return or exacerbation of symptoms may occur
following treatment for anxiety disorders and depression [9,10].
The primary aim of the present study was to test the hypothesis
that the benefits observed at post-treatment and 3-month follow-
up would be maintained at 12-month follow-up. Previous results
indicate that benefits of guided internet interventions for anxiety
or depression [11,12,13] are sustained in the longer-term, but
limited data exist for longer-term benefits of self-guided internet
interventions [14]. An additional aim was to examine the number
of participants who deteriorated at 12-month follow-up, defined as
an increase in PHQ-9 or GAD-7 scores of 5 or more points from
pre-treatment. No formal hypothesis was generated with respect to
deterioration, but this data was collected to provide information
about the safety of the Wellbeing Course.
Methods
Ethics Statement and Trial Registration
The original study [8] was approved by the Human Research
Ethics Committee (HREC) of the University of New South Wales
(UNSW, Sydney, Australia) and ratified by the Macquarie
University HREC (Sydney, Australia; HREC Reference:
5201100226). The original protocol included telephone interviews
at recruitment and a fourth group who received weekly contact
with a therapist. However, in order to focus on the benefits of
providing automatic emails during self-guided treatment and to
simulate an entirely automated treatment process, the interviews
and this fourth group were omitted from the final design. The trial
was registered with the Australian and New Zealand Clinical
Trials registry as ACTRN12610001058066. The protocol for this
trial and supporting CONSORT checklist are available as
supporting information; see Checklist S1 and Protocol S1.
Design and Sample Size
The original trial randomly allocated 257 participants to one of
two Treatment Groups or to a Waitlist Control Group.
Participants in the Treatment Plus Automated Email Group
(TEG; n = 100) received access to the Wellbeing Course with
automated emails. Participants in the Treatment Group (TG;
n = 106) received access to the Wellbeing Course without
automated emails. The Control Group (Controls; n = 51) received
access to the same treatment as the TEG following post-treatment;
the data presented here are the data for the Control Group in
Treatment, that is, after the Two Treatment Groups completed
treatment and the Control Group received treatment.
Measures
The primary outcome measures were depression and anxiety
symptom severity, as measured by the PHQ-9 and GAD-7. The
GAD-7 has good convergent validity with other anxiety scales
[15–17], is sensitive to DSM-IV congruent generalised anxiety
disorder, social phobia and panic disorder, with increasing scores
indicating greater symptom severity [16]. A total score of 8 on the
GAD-7 has been identified as an important threshold for
identifying the presence of an anxiety disorder [15–17]. A total
score of 10 on the PHQ-9 has been identified as an important
threshold for identifying DSM-IV congruent depression with
increasing scores indicating greater symptom severity [15,17-20].
Additional information collected comprised demographic details
including: age, gender, educational qualifications, vocational
status, treatment satisfaction and completion rates (i.e., percentage
in each treatment group who read all five online lessons of the
Wellbeing Course). Additional measures included changes in
health status and service utilisation, which will be reported
separately as part of an evaluation of the cost-effectiveness of the
intervention.
TEG and TG participants completed the PHQ-9 and GAD-7 at
pre-treatment, prior to each of the five lessons, at post-treatment,
3-month follow-up and 12-month follow-up. Control Group
participants completed the PHQ-9 and GAD-7 at pre-treatment
and post-treatment and, subsequently, commenced the same
intervention as the TEG group with data collected at pre-
treatment, prior to each lesson, at post-treatment, 3 month follow-
up and 12 month follow-up. Their results after they received and
completed the treatment phase are presented here as a partial
replication in order to test the reliability of the TEG condition.
Intervention
The Wellbeing Course is a five lesson transdiagnostic internet
intervention based on a pragmatic model of psychotherapeutic
change that assumes that symptoms of anxiety and depression are
the result of unhelpful habits of thought and action, that is,
maladaptive cognitions and behaviours [8,22]. This model also
proposes that interventions that are structured, systematically
present increasingly complex material over weeks and months, and
are sufficiently engaging to achieve adherence and commitment,
will result in reductions in unhelpful habits and an increase in
adaptive habits. Further, such interventions are likely to result in
large and sustained improvements in symptoms compared to
sporadic or unstructured therapy sessions, which may only result
in short-term symptom relief. More details about the Wellbeing
Course can be found elsewhere [8].
Procedure
TEG and TG participants received an email at the start of the
Course providing guidelines and a recommended timetable of
Course-related activities. TEG participants also received at least
two additional emails per week during the Course. Emails were
triggered when (1) participants read a Lesson, (2) if participants
had not read a prescribed Lesson within 7 days of it becoming
available, (3) at the start of each week, and (4) at times during the
Course when participants were known to experience increased
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symptoms or to have increased difficulties practicing skills (e.g.,
during the weeks when graded exposure was introduced). Emails
were comprised of three or four sentences, used the participant’s
first name, and employed a warm and supportive tone. The
content informed participants about newly available or unread
materials, reinforced progress and skills practice, normalised the
challenges of learning new skills, and encouraged realistic
expectations of recovery. All participants consented to receive
the emails and no emails contained personal or detailed clinical
information.
Up to five automated email reminders were sent to all
participants to complete post-treatment or follow-up question-
naires. These emails were only sent where participants had not
completed the questionnaires. Once participants had completed
the questionnaires they were sent a brief template-based feedback
email detailing their results. At the 3- and 12-month follow-up
time points participants who had not completed the questionnaires
after the five automated emails were telephoned once by the
researchers. No clinical contact was made between the 3- and 12-
month follow-up periods and no clinical content was discussed in
these telephone calls. The Course material was made available for
the 12-month period following the end of the 8-week treatment.
Statistical methods
Consistent with the initial report of this trial [8], several separate
mixed-models analyses were employed to analyse the data at post-
treatment, 3-month and 12-month follow-up. These mixed-models
employed an autoregressive covariance structure and maximum
likelihood estimation, which provides unbiased estimates in the
case of missing data; under the assumption that data is missing at
random. These mixed-models specified Group (i.e., TEG and TG)
and Time (i.e., pre-treatment, post-treatment, 3-month follow-up
and 12-month follow-up) as fixed effects with the Intercept set at
pre-treatment and Participants specific as a random effect.
Primary interest was the Group x Time interactions and
differences within and between the two Treatment Groups at
the different time points were examined using pairwise compar-
isons. Consistent with the original report of this study [8], one set
of analyses was conducted using the entire data set (i.e., the Overall
Sample) and a second set of analyses was restricted to participants
with elevated symptoms of both anxiety and depression (i.e., the
Comorbid Sample), defined by pre-treatment scores above clinical
cut-offs on both primary outcome measures (i.e., total GAD-7 $8
and total PHQ-9 $10). Effect sizes (Cohen’s d) and 95%
confidence intervals were calculated for both within-group and
between-group effects based on the pooled standard deviation. All
analyses were performed in SPSS version 19.0 (SPSS, Inc.,
Chicago, IL).
As described in recent dissemination studies [23], pre-treatment,
post-treatment and follow-up PHQ-9 and GAD-7 scores were
compared with clinical cut-offs to provide an index of clinically
significant remission. This was defined as the proportion of
participants who initially scored at or above the clinical cut-offs
and then subsequently below the clinical cut-offs. Finally, the
proportion of participants with significant deterioration in PHQ-9
or GAD-7 scores were reported, calculated for each group based
on a completer analysis and defined as an increase in PHQ-9 or
GAD-7 scores of five or more points from pre-treatment [15]. In
these analyses, missing values were handled using the Multiple
Imputation [21] procedure where Group as well as GAD-7 and
PHQ-9 scores at each time point were used to generate 20 sets of
imputed data. These 20 imputed data sets where then averaged to
provide pooled frequency counts, chi-square statistics and p values.
All results are reported also presented for the Waitlist Control
Group, after they had received treatment, as a partial replication
of the results of the TEG group.
Results
Adherence and Attrition
Twelve-month follow-up data were collected from 81%, 78%
and 87% of TEG, TG and treated Waitlist Control Group
participants, respectively.
Between post-treatment and follow-up participants in both
treatment groups continued to log in and read the online
materials. At the 12-month follow-up there was no longer a
significant difference in the number of TEG (68%) and TG (59%)
participants who had read the five lessons, that is, completed the
Course, X2 (1) = 1.63, p = .20. Similarly, in the Comorbid Sample,
no significant difference was found between the TEG (66%) and
TG (59%) participants who had completed the Course at 12-
month follow-up, X2 (1) = 0.67, p = .41.
Primary Outcome Measures
Means for the PHQ-9 and GAD-7 at each time point are
included in Table 1 and Figure 1 for the Overall Sample. Means
for the Comorbid Sample are shown in Table 2 and Figure 1.
Overall Sample. The mixed-model analyses examining
GAD-7 scores for the Overall Sample revealed a significant effect
for Time (F3, 467 = 87.57, p,.001), but not for Group (F1,
212 = 0.11, p = .74) or the Time by Group interaction (F3,
467 = 1.27, p = .28). Pairwise comparisons revealed no significant
differences between the TEG and TG groups at post-treatment, 3-
month follow-up or 12-month follow-up (p range = .14 to .69).
Both the TEG and TG groups improved significantly from pre-
treatment to post-treatment (p,.001), but did not obtain any
further significant changes from post-treatment to 3-month follow-
up (p..05) or from 3-month follow-up to 12 month follow-up
(p..05). However, the scores of both groups remained significantly
lower at 3- and 12-month follow-up compared with pre-treatment
(p,.001), indicating that symptom improvements were main-
tained.
Similarly, the mixed-model analyses examining PHQ-9 scores
for the Overall Sample revealed a significant effect for Time (F3,
471 = 74.48, p,.001), but not for Group (F1, 219 = 0.01, P = .93) or
the Time by Group interaction (F3, 471 = 0.79, p = .50). Pairwise
comparisons revealed no significant differences between the TEG
and TG groups at post-treatment, 3-month follow-up, and 12-
month follow-up (p range = .35 to .81). However, both the TEG
and TG groups improved significantly from pre-treatment to post-
treatment (p,.001), but did not obtain any further significant
changes from post-treatment to 3-month follow-up (p..05) or
from 3-month follow-up to 12-month follow-up (p..05). The
scores of both groups were sustained and remained significantly
lower at 3- and 12-month follow-up compared with pre-treatment
(p,.001).
Comorbid Sample. The mixed-model analyses for the
GAD-7 scores for the Comorbid Sample revealed a significant
effect for Time (F3, 258 = 69.03, p,.001) and Group (F1, 126 = 4.21,
p = .042), but not the Time by Group interaction (F3, 258 = 1.63,
p = .18). Pairwise comparisons revealed that both the TEG and
TG groups improved significantly from pre-treatment to post-
treatment (p,.001), but did not obtain any further significant
changes from post-treatment to 3-month follow-up (p..05) or
from 3-month follow-up to 12-month follow-up (p..05). The
scores of both groups were sustained and remained significantly
lower at 3- and 12-month follow-up compared with pre-treatment
(p..001). Pairwise comparisons also revealed the TEG group had
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significantly lower scores than the TG group at post-treatment and
3-month follow-up (p range = .01 to .03), but not at 12-month
follow-up (p = .75).
The mixed-model analyses of the PHQ-9 scores for the
Comorbid Sample revealed a significant effect for Time (F3,
268 = 72.58, p,.001), but not for Group (F1, 138 = 2.24, p = .14) or
the Time by Group interaction (F3, 268 = 2.27, p = .08). Pairwise
comparisons revealed that both the TEG and TG groups
improved significantly from pre-treatment to post-treatment
(p,.001), but did not obtain any further significant changes from
post-treatment to 3-month follow-up (p..05) or from 3-month
follow-up to 12-month follow-up (p..05). The scores of both
groups were sustained and remained significantly lower at 3- and
12-month follow-up compared with pre-treatment (p..001).
Pairwise comparisons also revealed the TEG group had signif-
icantly lower scores than the TG group at post-treatment and 3-
month follow-up (p range = .02 to .04), but not at 12-month
follow-up (p = .99).
Waitlist Control Group (following treatment). The
mixed-model analyses examining the scores of those in the
Waitlist Control Group following treatment revealed significant
effects for Time on both the GAD-7 (F3, 95.38 = 12.80, p,.001) and
PHQ-9 (F3, 97.99 = 15.71, p,.001). Pairwise comparisons revealed
significant improvements on both the PHQ-9 and GAD-7 from
pre-treatment to post-treatment (p,.001), but no significant
changes from post-treatment to 3-month follow-up (p..05) or
from 3-month follow-up to 12-month follow-up (p..05). However,
3-month follow-up and 12-month follow-up scores on the PHQ-9
and GAD-7 remained significantly lower than pre-treatment
scores (p,.001), indicating that the treatment effects were
maintained.
Effect Sizes
Within- and between-group effect sizes for the outcome
measures are included in Tables 1 and 2. For both the Overall
and Comorbid Samples large within-group effect sizes (i.e., $0.80)
were found for the TEG and moderate-to-large within-group (i.e.,
$0.50) effect sizes were found for the TG. Similar large within-
group effect sizes were observed in the Control Group following
treatment. Small and non-significant between-group effect sizes
(i.e., #0.30) were found between the two Treatment Groups.
Small-to-moderate between-group effect sizes were found between
the Comorbid Samples (i.e., 0.30 to 0.50) at each of the time
points, except at 12-month follow-up time point, when the effect
sizes were small and non-significant (i.e., #0.30).
Clinical Significance
Overall Sample. As shown in Table 3, post-treatment
remission rates for the PHQ-9 and GAD-7 were sustained at the
12-month follow-up time points for the TEG (64.7% and 63.1%)
and TG (68.6% and 60.8%).
Comorbid Sample. As shown in Table 3, the post-treatment
remission rates were also sustained at 12-month follow-up for the
Comorbid Samples of the TEG (73%) and TG (74%).
Figure 1. Means for the PHQ-9 and GAD-7 for the Overall and Comorbid Samples. Note: TEG: Treatment plus automated email group. TG:
Treatment group. PHQ-9: Patient Health Questionnaire-9 Item. GAD-7: Generalised Anxiety Disorder-7 Item.
doi:10.1371/journal.pone.0089591.g001
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Waitlist Control Group (following treatment). The re-
mission rates for the Control Group and the remission rates for the
Comorbid Sample of the Waitlist Control Group following
treatment were also sustained at 12-month follow-up.
Deterioration
Overall Sample. At 12-month follow-up, up to 3.3% of TEG
and 5.0% of TG participants obtained PHQ-9 or GAD-7 scores
five or more points higher compared to pre-treatment. No Waitlist
Control Group participants had scores five or more points higher
after treatment at 12-month follow-up.
Comorbid Sample. At 12-month follow-up, 3.0% of TEG
and 1.8% of TG participants in the Comorbid Samples obtained
PHQ-9 or GAD-7 scores five or more points higher compared to
pre-treatment.
Discussion
The primary finding from this study was that the self-guided
Wellbeing Course resulted in clinically significant reductions in
symptoms of anxiety and depression at post-treatment and these
reductions were sustained at the 3- and 12-month follow-up time
points. These findings are consistent with results from clinician-
guided internet interventions, which demonstrate that benefits are
sustained in the longer term [11,12] indicating the robust nature of
internet interventions. The magnitude of clinical benefits from this
self-guided intervention at 12-month follow-up were larger than
those reported at follow-up than other self-guided internet
treatments for depression or anxiety [12,24]. Benefits from the
present trial also compare favourably with self-guided internet
treatments for depression or anxiety where participants had
contact with researchers at pre-treatment [25,26], with trials of
transdiagnostic internet interventions involving clinician guidance
[27,28,29] and trials of clinician-guided transdiagnostic interven-
tions administered face-to-face [30]. However, while the magni-
tude of gains reported here are encouraging, caution should be
exercised in making comparisons across studies due to differences
in samples, inclusion criteria, and methodologies.
An important secondary finding of the present study was that
the benefits of automated emails, in increasing completion rates
and in reducing symptoms in a subsample with elevated and
comorbid symptoms, were no longer found at 12-month follow-up.
In the present study, at 12-month follow-up, the TG obtained
similar outcomes to the TEG on both the PHQ-9 and GAD-7 and
both groups evidenced remission rates above 50% at 12-month
follow-up in each group. Rates of deterioration at 12-month
follow-up appeared larger in the TG, but the overall event rate
was low (,5%).
The absence of benefits from automated emails appears to have
been the result of continued improvements in the TG group, of
whom an additional 25% completed the Course between the 3-
and 12-month follow-up points; compared to 7% of the TEG
group. Consequently, at 12-month follow-up, there was no
difference between groups in the proportion who had read all
five lessons or in the clinical outcomes of either the Overall or
Comorbid Samples. The reasons for this increase in completion
rates in the TG are unclear. However, it is possible that the
automated assessment emails at post-treatment and 3-month
follow-up prompted TG participants to return to the Course,
although it is also likely that participants found the material in the
Course sufficiently helpful in the first instance to justify their
return.
These results raise the question of whether automated emails
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emails facilitated more rapid symptom improvement with the
Comorbid Sample who received automated emails relative to the
Comorbid sample who did not receive emails. However, the
results indicate that the automated emails were not absolutely
necessary to achieve comparable outcomes in the longer term, as the
TG group obtained similar outcomes as the TEG at the 12-month
follow-up. This indicates that the decision about whether or not to
include automated emails should be informed by the costs, risks
and the benefits of their implementation and the value a service
places on the speed of clinical improvements. Nevertheless, it is
likely that more rapid reductions in symptoms would be associated
with reduced health costs and lifetime burden of disease.
Therefore, the inclusion of automated emails is recommended.
These results also extend debate and questions about the
mechanisms of change in internet interventions [31]. The
magnitude of clinical benefits found in this study indicates that,
at least for some patients, direct contact with a therapist is not
necessary for clinically significant change to occur during internet
treatment. This is not to say that therapeutic factors that facilitate
engagement and adherence, such as the credibility of an
intervention, reinforcement and unconditional positive regard,
are not important. Rather, we contend that these and other factors
can and should be integrated into the content, format and
presentation of self-guided interventions. We suspect that as
improvements are made to the content of internet-delivered
psychotherapeutic interventions and in the delivery of that
content, an increasing proportion of the population will be able
to benefit from them. However, we caution against assuming that
self-help materials can be easily developed and delivered. Just as
therapists require careful training and supervised practice, internet
intervention materials should also be carefully developed and
improved through a process of repeated clinical evaluation and
quality assurance cycles.
We also contend that these results provide support for
pragmatic models of psychotherapeutic change, which emphasise
the importance of systematically learning, practicing and adopting
core psychological skills. These skills support participants to
change unhelpful habits of thought and action, which, in turn,
have broad positive impacts on emotion dysregulation. We suspect
the use of case-enhanced learning strategies (e.g., detailed case
studies) in the course content facilitated engagement and
adherence. However, as noted by others, multiple other factors
such as providing a clear deadline and expectations of feedback
also facilitate adherence and clinical outcomes [26]. It appears
likely that systematic examination of other strategies to promote
engagement and adherence in self-guided internet interventions,
including prompts delivered by mobile technologies, will further
improve outcomes in self-guided internet-delivered interventions
and will also have utility across a broad range of health conditions
[32].
Limitations
These findings need to be considered in the context of the
limitations of the overall study. The long-term effects of the study
were not assessed alongside an active control group, although the
large magnitude of the outcomes indicates there were strong
treatment effects. The generalisability of these results is limited by
the nature of the sample, which comprised people seeking internet-
delivered treatment for anxiety and depression. However, it is
important to note that a comparison of demographic and
symptom profiles of participants in internet trials with those
identified in epidemiological samples indicates that the results of
Table 3. Proportion of participants in the Overall and Comorbid Sample, above and below cut-off scores of clinical significance
(remission).
Overall Sample TEG TG Chi Square
Waitlist Control Group (In
Treatment)c
N % N % TGE vs. TG N %
PHQ-9
Pre-treatment score . 10/Total 68/100 68.0 67/106 63.2 X2 (1) = 0.52, P = .46 22/42 52.3
Post-treatment score , 10 (Remission)/Total 42/68 61.7 42/67 62.6 X2 (1) = 0.11, P = .81 14/22 63.6
3-month follow-up score , 10 (Remission)/Total 51/68 75.0 46/67 68.6 X2 (1) = .82, P = .48 15/22 68.1
12-month follow-up score ,10 (Remission)/Total 44/68 64.7 46/67 68.6 X2 (1) = 0.36, P = .62 14/22 63.6
GAD-7
Pre-treatment score . 8/Total 76/100 76.0 74/106 69.8 X2 (1) = 0.99, P = .31 22/42 52.3
Post-treatment score , 8 (Remission)/Total 47/76 61.8 46/74 62.1 X2 (1) = 0.17, P = .76 10/22 45.5
3-month follow-up score , 8 (Remission)/Total 51/76 67.1 48/74 64.8 X2 (1) = 0.22, P = .72 15/22 68.1
12-month follow-up score ,8 (Remission)/Total 48/76 63.1 45/74 60.8 X2 (1) = 0.29, P = .66 14/22 63.6
Comorbid Sample
Pre-treatment PHQ-9 score . 10 and GAD-7
score . 8/Total
60/100 60.0 54/106 50.0 X2 (1) = 1.70, P = .19 19/42 45.2
Post-treatment PHQ-9 score , 10 and GAD-7
score ,8 (Remission)/Total
43/60 71.6 38/54 70.3 X2 (1) = 0.09, P = .81 14/19 73.6
3-month follow-up PHQ-9 score , 10 and
GAD-7 score ,8 (Remission)/Total
51/60 85.0 39/54 72.2 X2 (1) = 2.82, P = .16 14/19 73.6
12-month follow-up PHQ-9 score , 10 and
GAD-7 score ,8 (Remission)/Total
44/60 73.0 40/54 74.0 X2 (1) = 0.23, P = .71 14/19 73.6
Note. All data within table is pooled data from 20 generated sets of imputed data using the Multiple Imputation procedure.
doi:10.1371/journal.pone.0089591.t003
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internet trials may generalise to the wider population [33].
Moreover, while symptom improvements were sustained, the
present study relied on self-report measures rather than structured
diagnostic interviews, which would have required clinical contact
and may have affected outcomes. It is also important to note that
the present study employed a specific transdiagnostic treatment
intervention, the Wellbeing Course, which was designed and
developed for use as either an entirely self-guided or clinician-
guided Course. Consequently, it is possible that automated emails
may facilitate greater adherence and clinical outcomes in less
developed interventions or interventions initially developed to
involve clinician guidance but subsequently used in a self-guided
format.
Conclusions
The present results indicate that the benefits of the self-guided
Wellbeing Course were sustained at 12-month follow-up. The
inclusion of automated emails facilitated adherence, completion
and more rapid symptom reduction during the Wellbeing Course
in the immediate and short-term for those with comorbid
symptoms. However, these emails did not improve outcomes any
further in the longer term or for the overall group. We contend
that automated emails are helpful, particularly for those with
elevated symptoms, and should be considered when developing
self-guided and clinician-guided interventions where possible.
Overall, the Wellbeing Course was clinically effective and
acceptable to consumers. These results are encouraging and
indicate the public health potential of well-developed self-guided
interventions.
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